celecoxib has been researched along with natriuretic peptide, brain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geisslinger, G; Tegeder, I | 1 |
| Grüber, M; Hasenfuss, G; Jacobshagen, C; Kögler, H; Maier, LS; Nguyen, VP; Schmidt, AG; Teucher, N; Toischer, K; Unsöld, BW | 1 |
| Cai, Y; Chen, S; Feng, X; Gao, S; Huang, X; Li, H; Li, Q; Liu, P; Liu, Z; Lu, J; Ye, J | 1 |
1 review(s) available for celecoxib and natriuretic peptide, brain
| Article | Year |
|---|---|
Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?
Topics: Cardiovascular Diseases; Celecoxib; Cell Proliferation; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Heart Failure; Hemostasis; Humans; Hypertension; Lactones; Naproxen; Natriuretic Peptide, Brain; Peptide Fragments; Pyrazoles; Sulfonamides; Sulfones | 2006 |
2 other study(ies) available for celecoxib and natriuretic peptide, brain
| Article | Year |
|---|---|
Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction.
Topics: Animals; Blood Pressure; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Activation; Female; Glycogen Synthase Kinase 3; Heart Failure; Insulin; Mice; Mice, Inbred C57BL; Muscle Proteins; Myocardial Contraction; Myocytes, Cardiac; Natriuretic Peptide, Brain; Phenylephrine; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrazoles; Rabbits; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sulfonamides; Ventricular Dysfunction, Left | 2008 |
COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Topics: Animals; Animals, Newborn; Calcineurin; Cardiomegaly; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclosporine; Dinoprostone; Endothelin-1; Gene Expression Regulation; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Nitrobenzenes; Primary Cell Culture; Promoter Regions, Genetic; Protein Binding; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Sulfonamides; Transcription, Genetic | 2014 |